Humana Inc.
400.02USD
-3.0700 (-0.76%)
Revenue
| (USD) | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|---|---|
| FY | 92.9B | 106.4B | 117.8B | 129.7B | 162.8B | 168.6B |
| Q1 | 24.0B | 26.7B | 29.6B | 32.1B | 39.6B | — |
| Q2 | 23.7B | 26.7B | 29.5B | 32.4B | — | — |
| Q3 | 22.8B | 26.4B | 29.4B | 32.6B | 40.9B | — |
| Q4 | 22.4B* | 26.5B* | 29.2B* | 32.5B* | 41.2B | — |
Revenue
| (USD) | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|---|---|
| FY | 22.08 | 20.00 | 9.98 | 9.84 | 9.15 | 16.57 |
| Q1 | 7.29 | 9.87 | 6.11 | 10.30 | 9.83 | — |
| Q2 | 5.48 | 7.66 | 5.62 | 4.51 | — | — |
| Q3 | 9.39 | 6.71 | 3.98 | 1.62 | -.938 | — |
| Q4 | -.118* |
Fiscal period: Reported, Estimated. Reported figures: SEC filings (EDGAR). Estimates are sell-side consensus for periods that have not reported. Cells marked * were synthesized from the annual filing less the year-to-date figures, because the quarter was not filed on its own. Earnings per share are restated onto today's share basis, so a period before a stock split is comparable with the ones after it.
| -4.35* |
| -5.73* |
| -6.59* |
| -7.92 |
| — |